Bio-Techne Corp (TECH) Stock Price, Quote & News

Latest News on TECH

Feb 20, 2025, 7:00 AM EST - 3 days ago

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

Feb 18, 2025, 7:00 AM EST - 5 days ago

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

Feb 5, 2025, 2:24 PM EST - 17 days ago

Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript

Feb 5, 2025, 6:30 AM EST - 18 days ago

Bio-Techne Declares Dividend

Feb 5, 2025, 6:30 AM EST - 18 days ago

Bio-Techne Releases Second Quarter Fiscal 2025 Results

Feb 4, 2025, 7:00 AM EST - 19 days ago

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

Jan 21, 2025, 7:00 AM EST - 4 weeks ago

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

Jan 21, 2025, 7:00 AM EST - 4 weeks ago

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

Jan 10, 2025, 7:00 AM EST - 6 weeks ago

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Jan 8, 2025, 7:00 AM EST - 6 weeks ago

BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025

Jan 8, 2025, 7:00 AM EST - 6 weeks ago

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

Jan 7, 2025, 7:00 AM EST - 6 weeks ago

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

Dec 20, 2024, 7:00 AM EST - 2 months ago

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Dec 19, 2024, 7:00 AM EST - 2 months ago

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

Dec 18, 2024, 7:00 AM EST - 2 months ago

ScaleReady awards a G-Rex® Grant to Moonlight Bio

Dec 12, 2024, 7:00 AM EST - 2 months ago

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

Dec 10, 2024, 7:00 AM EST - 2 months ago

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

Nov 27, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

Nov 25, 2024, 9:02 AM EST - 3 months ago

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne

Nov 22, 2024, 9:00 AM EST - 3 months ago

OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements

Nov 20, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

Nov 18, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

Nov 14, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

Nov 11, 2024, 5:47 PM EST - 3 months ago

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

Nov 11, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

Nov 8, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

Nov 7, 2024, 7:00 AM EST - 3 months ago

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

Nov 6, 2024, 7:00 AM EST - 3 months ago

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

Nov 5, 2024, 7:00 AM EST - 3 months ago

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH

Oct 30, 2024, 3:48 PM EDT - 4 months ago

Bio-Techne Corporation (TECH) Q1 2025 Earnings Call Transcript

Oct 30, 2024, 7:49 AM EDT - 4 months ago

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise

Oct 30, 2024, 6:30 AM EDT - 4 months ago

BIO-TECHNE DECLARES DIVIDEND

Oct 30, 2024, 6:30 AM EDT - 4 months ago

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS

Oct 29, 2024, 7:00 AM EDT - 4 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics

Oct 10, 2024, 7:00 AM EDT - 4 months ago

BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS

Oct 9, 2024, 7:00 AM EDT - 4 months ago

ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences

Oct 8, 2024, 7:00 AM EDT - 4 months ago

ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute

Oct 7, 2024, 7:00 AM EDT - 4 months ago

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

Sep 26, 2024, 7:00 AM EDT - 5 months ago

LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

Sep 24, 2024, 7:00 AM EDT - 5 months ago

BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING

Sep 18, 2024, 7:00 AM EDT - 5 months ago

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

Sep 18, 2024, 7:00 AM EDT - 5 months ago

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

Sep 17, 2024, 7:00 AM EDT - 5 months ago

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

Sep 17, 2024, 7:00 AM EDT - 5 months ago

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

Sep 16, 2024, 7:00 AM EDT - 5 months ago

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

Aug 27, 2024, 7:00 AM EDT - 6 months ago

ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine

Aug 26, 2024, 7:00 AM EDT - 6 months ago

BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

Aug 7, 2024, 7:30 AM EDT - 7 months ago

Bio-Techne meets Q4 profit estimates on demand for its diagnostics products

Aug 7, 2024, 6:30 AM EDT - 7 months ago

BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS

Jul 31, 2024, 7:00 AM EDT - 7 months ago

Market Cap	10.26B
Revenue (ttm)	1.16B
Net Income (ttm)	168.11M
EPS (ttm)	N/A
PE Ratio	39.88
Forward PE	39.45
Profit Margin	14.50%
Debt to Equity Ratio	0.14

Volume	1,973,300
Avg Vol	1,139,584
Day's Range	N/A - N/A
Shares Out	158.09M
Stochastic %K	17%
Beta	1.27
Analysts	Strong Sell
Price Target	$85.58